Glucose metabolism in cirrhosis: a review with some perspectives for the future (Q38756310)

6 September 2017

1 reference

title

Glucose metabolism in cirrhosis: a review with some perspectives for the future (English)

1 reference

6 September 2017

2

DeFronzo RA

1 reference

6 September 2017

Petrides AS

1

1 reference

6 September 2017

1 December 1989

1 reference

Diabetes/metabolism reviews

6 September 2017

1 reference

6 September 2017

5

1 reference

6 September 2017

691-709

1 reference

6 September 2017

8

1 reference

Carbohydrate metabolism studies in cirrhosis of the liver

6 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

A study of carbohydrate metabolism in postnecrotic cirrhosis liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Glucose intolerance in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Cirrhosis and diabetes. I. Increased incidence of diabetes in patients with Laennec's cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Regulation of hepatic glucose metabolism in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin resistance in cirrhosis: evidence for a post-receptor defect.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The euglycemic clamp technique in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin action in cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The mechanism of the carbohydrate intolerance of cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Role of insulin receptors in insulin-resistant states

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Role of liver in insulin physiology

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hypersecretion of proinsulin does not explain the hyperinsulinaemia of patients with liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Proinsulin and C-peptide: A review

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

C-peptide and Insulin in Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Degradation and Secretion of Insulin in Hepatic Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin uptake by the human alcoholic cirrhotic liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Impaired early insulin response to intravenous glucose in alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperinsulinemia does not compensate for peripheral insulin resistance in obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Feedback inhibition of insulin secretion is altered in cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hepatic and renal metabolism before and after portasystemic shunts in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin kinetics after portal and peripheral injection of [125I] insulin. I. Data analysis and modeling

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Carbohydrate storage in man: speculations and some quantitative considerations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The disposal of an oral glucose load in healthy subjects. A quantitative study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Net splanchnic glucose production in normal man and in various disease states

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Evidence for an Augmented Glucagon Dependence of Hepatic Glucose Production in Cirrhosis of the Liver*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Nature and quantity of fuels consumed in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin resistance in human liver cirrhosis is not modified by porto-systemic surgical shunt.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hemodynamic studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Metabolic consequences of portacaval shunting in the rat: Effects on glucose tolerance and serum immunoreactive insulin response

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effects of portacaval anastomosis on glucose tolerance in the dog: evidence of an interaction between the gut and the liver in oral glucose dosposal

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Erythrocyte insulin receptors in patients with chronic liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Decreased insulin binding to red blood cells in liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Down-Regulation of Insulin Receptors in Postnecrotic Cirrhosis of Liver*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin binding to erythrocytes in hyperinsulinemic patients with precirrhotic hemochromatosis and cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin receptor assays used in human studies: merits and limitations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

A critical interpretation of experiments of binding of peptide hormone to specific receptors by computer modelling

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperglucagonemia and insulin-mediated glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The effect of growth hormone on glucose metabolism and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Epinephrine-induced insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Plasma free fatty acid in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Individual free fatty acids in patients with liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Plasma long chain fatty acids and esterified lipids in cirrhosis and hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Total and individual free fatty acid concentrations in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effect of long chain triglyceride infusion on glucose metabolism in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: Responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Elevated plasma glucagon levels in cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Impaired glucose tolerance and growth hormone in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Glucoregulatory response to insulin-induced hypoglycemia in Laennec's cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

17-Hydroxycorticosteroid metabolism in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Adrenocortical steroid metabolism and adrenal cortical function in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Short-term regulation of insulin receptor affinity in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Characterization and partial purification of a factor from uremic human serum that induces insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Abnormal carbohydrate metabolism in patients with liver cirrhosis; in vitro study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin resistance in uremia mediated by postbinding defects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Effect of muscle glycogen depletion on in vivo insulin action in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610050805

7 January 2021

Identifiers

DOI

10.1002/DMR.5610050805

0 references

PubMed ID

2693018

1 reference

PubMed ID

2693018